Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb 29;10(1):23.
doi: 10.1186/s40942-024-00540-w.

Surgical management of retinal detachment and macular holes secondary to ocular toxoplasmosis: a systematic review and meta-analysis

Affiliations
Review

Surgical management of retinal detachment and macular holes secondary to ocular toxoplasmosis: a systematic review and meta-analysis

Dillan Cunha Amaral et al. Int J Retina Vitreous. .

Abstract

Background: Toxoplasma gondii causes ocular toxoplasmosis (OT), involving inflammation, scarring, and retinal complications. The OT complications were retinal detachment (RD), and retinal breakage (RB). Surgical interventions like scleral buckling (SB) and vitrectomy are common. Limited understanding exists of the safety and efficacy of surgical management of RD/RB secondary to OT. Another complication is toxoplasmosis-related macular holes (tMH), with sparse evidence on surgical outcomes. This meta-analysis aims to clarify clinical characteristics, and surgical results, and enhance understanding of RD, RB, and MH secondary to OT.

Methods: PubMed, Cochrane, Embase and Web of Science database were queried for retrospective studies, case series and case reports that provided information on RD, RB and MH associated with OT and reported the outcomes of: (1) Retinal reattachment of RD/RB and tMH closure; (2) Best-corrected visual acuity (BCVA) improvement; and (3) Complications. Heterogeneity was examined with I2 statistics. A random-effects model was used for outcomes with high heterogeneity. Statistical analysis was performed using the software R (version 4.2.3, R Foundation for Statistical Computing, Vienna, Austria).

Results: Fourteen final studies, comprising a total of 96 patients were analyzed, 81 with RD or RB and 15 with tMH. Overall, surgical management was associated with several advantages: a high rate of retinal reattachment of RD/RB of 97% (95% Confidence Interval [CI] 92-100%; I2 = 0%), retinal reattachment of just RD of 96% (95% CI 89-100%; I2 = 30%) and tMH closure 97% (95% CI 87-100; I2 = 12%). There were significant differences in BCVA after surgeries in studies of RD/RB (MD 0.60; 95% CI 0.35-0.65; I2 = 20%) and MH (MD 0.67; 95% CI 0.50-0.84; I2 = 0%). The overall complication rate associated with surgical procedures in RD/RB secondary to OT was confirmed to be 25%.

Conclusions: The systematic review and meta-analysis showed that the treatment approaches currently in use are effective, with a remarkable rate of retinal reattachment of RD/RB, tMH closure, and substantial improvements in visual acuity. More randomized, long-term studies on disease and surgical factors can provide valuable insights into their impact on anatomical and visual outcomes.

Keywords: Macular hole; Meta-analysis; Ocular toxoplasmosis; Retinal break; Retinal detachment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
PRISMA flow diagram of study screening and selection
Fig. 2
Fig. 2
A Retinal reattachment of the retinal detachment and retinal breakage. B Retinal reattachment of retinal detachment forest plot. C Toxoplasmosis-related macular hole closure
Fig. 3
Fig. 3
Development of retinal detachment or retinal breaks less than 1 year after retinochoroiditis forest plot
Fig. 4
Fig. 4
Recurrence of retinal detachment forest plot
Fig. 5
Fig. 5
A Best-corrected visual acuity mean difference after RD and RB surgical management forest plot. B Best-corrected visual acuity mean difference after MH surgical management forest plot
Fig. 6
Fig. 6
Complications associated with surgical management of retinal detachment secondary to ocular toxoplasmosis forest plot

References

    1. Delair E, Latkany P, Noble AG, Rabiah P, McLeod R, Brézin A. Clinical manifestations of ocular toxoplasmosis. Ocul Immunol Inflamm. 2011;19(2):91–102. doi: 10.3109/09273948.2011.564068. - DOI - PubMed
    1. Atmaca LS, Simsek T, Batioglu F. Clinical features and prognosis in ocular toxoplasmosis. Jpn J Ophthalmol. 2004;48(4):386–391. doi: 10.1007/s10384-003-0069-0. - DOI - PubMed
    1. Jasper S, Vedula SS, John SS, Horo S, Sepah YJ, Nguyen QD. Corticosteroids as adjuvant therapy for ocular toxoplasmosis. Cochrane Database Syst Rev. 2017;1(1):CD007417. - PMC - PubMed
    1. Song HB, Jung BK, Kim JH, Lee YH, Choi MH. Investigation of tissue cysts in the retina in a mouse model of ocular toxoplasmosis: distribution and interaction with glial cells. Parasitol Res. 2018;117(8):2597–2605. doi: 10.1007/s00436-018-5950-3. - DOI - PubMed
    1. Zamora DO, Rosenbaum JT, Smith JR. Invasion of human retinal vascular endothelial cells by Toxoplasma gondii tachyzoites. Br J Ophthalmol. 2008;92(6):852–855. doi: 10.1136/bjo.2007.133314. - DOI - PubMed

LinkOut - more resources